• S-Adenosylhomocysteine: Mechanism and Research Use

  2026-08-11

  S-Adenosylhomocysteine (SAH) is the product of S-adenosylmethionine-dependent methyltransferase reactions and a feedback inhibitor of methyltransferases. Its research value centers on methyltransferase inhibition, SAM/SAH ratio modulation, cystathionine β-synthase deficiency research, and controlled studies of homocysteine metabolism.

• Maternal Surgery, Calpain, and Offspring Cognition

  2026-08-10

  The reference study identifies excessive calpain activation as a mechanistic link between maternal non-obstetric surgery during pregnancy and later cognitive impairment in rat offspring. By combining behavioral, structural, and molecular analyses with postnatal calpain inhibition or TrkB activation, it connects hippocampal synaptic plasticity to a potentially modifiable pathway relevant to neuroprotection research.

• Clozapine N-oxide: From Circuit Perturbation to Proof

  2026-08-09

  Clozapine N-oxide (CNO) is more than a DREADDs ligand: it can test whether cell-type-specific suppression produces durable, pathway-selective synaptic plasticity. This article translates recent cortical findings into practical assay and control decisions for rigorous neuroscience research.

• EZ Cap™ OVA mRNA for Immune Research

  2026-08-08

  EZ Cap™ OVA mRNA is a Cap 1-capped Ovalbumin mRNA reagent for controlled antigen-expression experiments. Its defined transcript length, poly(A) tail, high capping efficiency, and cold-chain handling requirements support reproducible gene expression studies, immune response modeling, and vaccine development research.

• MDL 28170 Calpain Inhibitor Guide

  2026-08-07

  A scenario-based guide to using MDL 28170, Calpain and Cathepsin B Inhibitor, Selective (SKU A4412) in viability, apoptosis, neuroprotection, and protease-mechanism studies. It connects product chemistry and handling with recent calpain evidence while separating validated findings from practical workflow recommendations.

• Spermine Tetrahydrochloride: Next-Gen Polyamine for Translat

  2026-08-07

  Explore the mechanistic and translational power of Spermine tetrahydrochloride (N1,N1'-(butane-1,4-diyl)bis(propane-1,3-diamine) tetrahydrochloride) in stabilizing biological systems—from membrane protection to protein crystallization and NMDA receptor modulation. This thought-leadership article bridges rigorous structural biology with neurodegenerative models, offering strategic protocol guidance and a future-facing outlook for translational researchers.

• Mithramycin A: Anticancer Antibiotic Targeting G-C DNA Regio

  2026-08-06

  Mithramycin A is a well-characterized anticancer antibiotic that selectively binds G-C-rich DNA, inhibiting both transcription and replication. It serves as a potent c-myc expression inhibitor and inducer of myeloid differentiation, particularly valued in leukemia and cardiac research for its molecular precision.

• FPH1 (BRD-6125) for Reliable Hepatocyte Proliferation Assays

  2026-08-06

  FPH1 (BRD-6125) empowers researchers to expand primary human hepatocytes with donor-independent reproducibility, supporting drug discovery and iPS cell differentiation workflows. This guide details optimized protocols, troubleshooting strategies, and the integration of optogenetic innovations for advanced hepatic modeling.

• Gap19: Unraveling Connexin 43 Hemichannels for Translational

  2026-08-05

  This thought-leadership article delivers a mechanistic and strategic exploration of Gap19—a selective connexin 43 hemichannel blocker—detailing its unique role in dissecting neuroglial interactions, modulating inflammation, and advancing neuroprotection in translational research. Drawing from anchor literature and recent experimental advances, we bridge foundational biology with workflow guidance, positioning Gap19 as an indispensable tool for tackling cerebral ischemia, neuroinflammation, and macrophage polarization.

• VX-745: p38α MAPK Inhibitor for Translational Inflammation M

  2026-08-05

  VX-745, a highly selective p38α MAPK inhibitor provided by APExBIO, empowers translational researchers to dissect inflammation and stress signaling with unprecedented specificity. Its dual mechanism—blocking kinase activity and accelerating dephosphorylation—revolutionizes workflows in multiple myeloma, arthritis models, and beyond.

• L. plantarum P101 Attenuates Alcoholic Steatosis via AMPK Mo

  2026-08-04

  This study demonstrates that Lactiplantibacillus plantarum P101 reduces alcohol-induced hepatic lipid accumulation in mice by activating the AMPK signaling pathway. Integration of gut microbiota and metabolomics analyses reveals how probiotic-mediated metabolic changes underpin this protective effect, highlighting AMPK as a central node for intervention in alcoholic fatty liver disease.

• Applied Workflows with Anti-RPS6 Antibody in Ribosome Biogen

  2026-08-04

  Harness the Anti-RPS6 (7B10) Mouse Monoclonal Antibody to interrogate ribosome biogenesis and oncogenic signaling across Western blot, immunofluorescence, and immunoprecipitation workflows. This guide translates a pivotal LRRC8A–Caveolin-1 axis discovery into actionable protocols, troubleshooting strategies, and comparative insights for advanced cancer biology research.

• Structural Insights into the Nipah Virus Polymerase Complex

  2026-08-03

  The reference study provides high-resolution structural data on the Nipah virus (NiV) L-P polymerase complex, elucidating the molecular organization and interactions essential for viral RNA replication and transcription. These findings lay a foundation for rational antiviral design targeting this machinery, with significant implications for emerging zoonotic viruses lacking approved treatments.

• A23187, Free Acid: Calcium Ionophore Workflows & Troubleshoo

  2026-08-03

  A23187, free acid unlocks precision control of intracellular Ca2+ for dissecting apoptosis, signaling, and muscle contractility. This guide delivers actionable protocols, troubleshooting insights, and evidence-driven workflow enhancements—empowering researchers to maximize reproducibility and discovery impact with APExBIO's trusted reagent.

• Azilsartan (TAK-536): Precision Tools for RAS–SIRT3 and Neur

  2026-08-02

  Azilsartan (TAK-536) stands out as a potent, highly selective AT1 receptor inverse agonist, enabling unprecedented specificity in dissecting renin-angiotensin system (RAS) signaling within cardiovascular and neuroinflammatory research. Recent studies leverage its unique solubility and purity profile to unravel astrocyte–microglia interactions and optimize inflammation assays.

515 records 6/35 page Previous Next First page 上5页 678910 下5页 Last page